Jacob Chacko - 06 Feb 2024 Form 4 Insider Report for Oric Pharmaceuticals, Inc. (ORIC)

Signature
/s/ Christian Kuhlen, attorney-in-fact
Issuer symbol
ORIC
Transactions as of
06 Feb 2024
Net transactions value
-$489,346
Form type
4
Filing time
08 Feb 2024, 20:01:26 UTC
Previous filing
03 Jan 2024
Next filing
08 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORIC Common Stock Sale $169,160 -13,958 -1.7% $12.12 794,586 06 Feb 2024 Direct F1, F2
transaction ORIC Common Stock Sale $320,186 -26,042 -3.3% $12.30 768,544 07 Feb 2024 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 28, 2022.
F2 Represents the weighted average share price of an aggregate total of 13,958 shares sold in the price range of $12.00 to $12.31 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Represents the weighted average share price of an aggregate total of 26,042 shares sold in the price range of $12.11 to $12.40 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.